A Skin Image Reference Tool to Aid Healthcare Providers' Diagnosis
1 other identifier
observational
400
1 country
1
Brief Summary
Consented patients will have three images taken of their dermatologic conditions within the Belle.ai software. These images will be uploaded and saved within the Belle software system where a single AI-generated differential list will be generated based on the three photos. All photos uploaded will be de-identified. The software will not have any unique identifiers of participants saved in the system. The photos will be named based on participant enrollment numbers or unique code numbers and no unique identifiers will be attached to the photos. There will be no data collection form necessary for this study
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2025
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 13, 2025
CompletedFirst Posted
Study publicly available on registry
June 24, 2025
CompletedStudy Start
First participant enrolled
September 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
October 24, 2025
October 1, 2025
2 years
June 13, 2025
October 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
concordance of Belle.ai diagnoses with physician diagnoses.
The study coordinator will review uploaded patient "cases" and assign them for review and adjudication to designated Dermatologic Review Committee (DRC) members within the Belle web portal. The DRC will be comprised of 1-2 Advocate Health board-certified dermatologists from each of the Winston, Charlotte, and Midwest dermatology practices.
Day 1
Study Arms (1)
Patient at Advocate Health dermatology clinic
The study, subject recruitment, and analysis will be conducted within the Advocate Health system at Atrium Health Wake Forest Baptist (AHWFB) in Winston-Salem, NC. Recruiters for this study include Advocate Health dermatology attendings, fellows, and staff, who will capture images of patients presenting to Wake Forest Dermatology Clinics in Winston-Salem, NC.
Eligibility Criteria
Up to 400 participants will be recruited for this study
You may qualify if:
- Patient must present to an Advocate Health dermatology clinic
- Patient must have the ability and willingness to provide informed consent and comply with study procedures and visits
- Participant dermatologists must have access to the required technology (e.g., smartphone with internet access) and be capable of using it for the required image capture
You may not qualify if:
- Patients who are unable to comply with study procedures due to physical or mental health limitations (as assessed by study coordinator)
- Pediatric, adolescent, and teen patients who present with dermatological conditions on their genitalia will not be included in the study (in support of patient privacy concerns).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Wake Forest University Health Scienceslead
- BelleTorus Corporationcollaborator
Study Sites (1)
Wake Forest University Health Sciences Department of Dermatology
Winston-Salem, North Carolina, 27157, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lindsay C Strowd, MD
Wake Forest University Health Sciences
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 13, 2025
First Posted
June 24, 2025
Study Start
September 15, 2025
Primary Completion (Estimated)
September 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
October 24, 2025
Record last verified: 2025-10